April 16, 2013--BUSINESS WIRE--Allergan, Inc. today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter to its New Drug Application for Levadex inhalation aerosol for the acute treatment of migraine in adults.
http://www.drugs.com/nda/levadex_130416.html?
http://www.drugs.com/nda/levadex_130416.html?
No comments:
Post a Comment